Use of Tigecycline in Pediatric Patients With Infections Predominantly Due to Extensively Drug-Resistant Gram-Negative Bacteria | Zendy

Εlias Iosifidis | Zendy; A. Violaki | Zendy; Evangelia Michalopoulou | Zendy; Eleni Volakli | Zendy; Elisavet Diamanti | Zendy; Dimitrios Koliouskas | Zendy; Charalampos Antachopoulos | Zendy; Vasiliki DrossouAgakidou | Zendy; Μαρία Σδούγκα | Zendy; Emmanuel Roilides | Zendy

Open Access

Use of Tigecycline in Pediatric Patients With Infections Predominantly Due to Extensively Drug-Resistant Gram-Negative Bacteria

Author(s) -

Εlias Iosifidis,

A. Violaki,

Evangelia Michalopoulou,

Eleni Volakli,

Elisavet Diamanti,

Dimitrios Koliouskas,

Charalampos Antachopoulos,

Vasiliki DrossouAgakidou,

Μαρία Σδούγκα,

Emmanuel Roilides

Publication year - 2016

Publication title -

journal of the pediatric infectious diseases society

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.269

H-Index - 31

eISSN - 2048-7207

pISSN - 2048-7193

DOI - 10.1093/jpids/piw009

Subject(s) - tigecycline , medicine , colistin , antimicrobial , adverse effect , linezolid , antibiotics , minocycline , intensive care medicine , pediatrics , bacteria , microbiology and biotechnology , staphylococcus aureus , vancomycin , genetics , biology

Emergence of extensively drug-resistant (XDR) bacteria has forced clinicians to use off-label antimicrobial agents such as tigecycline. We present our experience on salvage use of tigecycline for the treatment of infections caused by XDR Gram-negative bacteria in critically ill children and review published cases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research